The pharmaceutical supply chain is undergoing a significant transformation, driven by upstream pressures from manufacturers. As drug production shifts towards more complex biologics and cell and gene therapies, the demand for sophisticated, temperature-controlled logistics is intensifying. These high-value, sensitive products require stricter handling protocols, pushing manufacturers to dictate